X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7543) 7543
Book Review (1377) 1377
Publication (303) 303
Newsletter (133) 133
Conference Proceeding (37) 37
Book Chapter (36) 36
Magazine Article (9) 9
Web Resource (6) 6
Dissertation (3) 3
Newspaper Article (2) 2
Report (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6531) 6531
index medicus (6390) 6390
female (3790) 3790
male (3654) 3654
azathioprine (3556) 3556
azathioprine - therapeutic use (3193) 3193
adult (3083) 3083
azathioprine - adverse effects (2700) 2700
middle aged (2466) 2466
immunosuppressive agents - therapeutic use (2306) 2306
immunosuppressive agents - adverse effects (2079) 2079
drug therapy, combination (1235) 1235
gastroenterology & hepatology (1213) 1213
aged (1199) 1199
adolescent (1122) 1122
treatment outcome (1097) 1097
abridged index medicus (1066) 1066
transplantation (1058) 1058
azathioprine - administration & dosage (1017) 1017
therapy (994) 994
kidney transplantation (963) 963
surgery (902) 902
retrospective studies (814) 814
inflammatory-bowel-disease (786) 786
immunosuppressive agents - administration & dosage (761) 761
child (728) 728
follow-up studies (727) 727
time factors (720) 720
prednisone - therapeutic use (718) 718
6-mercaptopurine (712) 712
cyclosporine - therapeutic use (711) 711
immunology (709) 709
crohn disease - drug therapy (694) 694
risk factors (657) 657
immunosuppression (650) 650
crohns-disease (591) 591
inflammatory bowel disease (559) 559
pharmacology & pharmacy (559) 559
cyclosporine (558) 558
crohn's disease (539) 539
infliximab (529) 529
inflammatory bowel diseases - drug therapy (513) 513
cyclosporine - adverse effects (495) 495
care and treatment (494) 494
mycophenolic acid - analogs & derivatives (494) 494
methotrexate (472) 472
drug therapy (460) 460
medicine, general & internal (460) 460
young adult (453) 453
mycophenolic acid - therapeutic use (443) 443
prospective studies (438) 438
ulcerative colitis (436) 436
colitis, ulcerative - drug therapy (435) 435
mercaptopurine - therapeutic use (426) 426
cyclophosphamide - therapeutic use (420) 420
corticosteroids (410) 410
animals (405) 405
methotrexate - therapeutic use (404) 404
kidney transplantation - immunology (401) 401
rheumatology (397) 397
adrenal cortex hormones - therapeutic use (392) 392
prednisolone - therapeutic use (390) 390
mercaptopurine - adverse effects (384) 384
prednisone - adverse effects (382) 382
pharmacogenetics (365) 365
transplantation, homologous (365) 365
immunosuppressive agents (363) 363
mycophenolate mofetil (363) 363
cyclophosphamide (358) 358
mycophenolate-mofetil (355) 355
pregnancy (352) 352
dermatology (340) 340
recurrence (332) 332
double-blind (329) 329
medicine & public health (329) 329
cyclosporins - adverse effects (322) 322
disease (321) 321
health aspects (321) 321
patients (321) 321
management (320) 320
child, preschool (317) 317
research (317) 317
remission induction (316) 316
dose-response relationship, drug (299) 299
efficacy (299) 299
glucocorticoids - therapeutic use (296) 296
prednisone - administration & dosage (295) 295
prednisone (290) 290
antibodies, monoclonal - therapeutic use (287) 287
recipients (287) 287
cyclophosphamide - adverse effects (286) 286
remission (285) 285
mercaptopurine (284) 284
prognosis (283) 283
analysis (282) 282
graft rejection - prevention & control (280) 280
immunosuppression - adverse effects (279) 279
ulcerative-colitis (279) 279
urology & nephrology (279) 279
anti-inflammatory agents - therapeutic use (278) 278
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6944) 6944
German (288) 288
French (144) 144
Spanish (120) 120
Japanese (57) 57
Italian (26) 26
Russian (25) 25
Polish (24) 24
Danish (17) 17
Korean (16) 16
Portuguese (14) 14
Hungarian (12) 12
Dutch (8) 8
Czech (7) 7
Chinese (4) 4
Hebrew (4) 4
Norwegian (4) 4
Croatian (3) 3
Finnish (3) 3
Swedish (3) 3
Bulgarian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Indian Journal of Pediatrics, ISSN 0019-5456, 10/2018, Volume 85, Issue 10, pp. 918 - 919
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12098-018-2687-z 
Medicine & Public Health | Pediatrics | Gynecology | PEDIATRICS | Azathioprine | Complications and side effects
Journal Article
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 01/2013, Volume 108, Issue 1, pp. 99 - 105
OBJECTIVES: The risk of non-Hodgkin's lymphoma (NHL) with tumor necrosis factor alpha (TNF-alpha) inhibitors is unclear, whether related to concomitant... 
RHEUMATOID-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | AZATHIOPRINE | RISK | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CANCER | MEDLINE | Azathioprine - therapeutic use | Lymphoma, T-Cell - chemically induced | Certolizumab Pegol | United States | Humans | Immunoglobulin Fab Fragments - adverse effects | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Polyethylene Glycols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Polyethylene Glycols - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Mercaptopurine - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Odds Ratio | United States Food and Drug Administration | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | SEER Program | Antibodies, Monoclonal, Humanized - therapeutic use | Psoriasis - drug therapy | Adverse Drug Reaction Reporting Systems | Risk Factors | Spondylitis, Ankylosing - drug therapy | Mercaptopurine - adverse effects | Immunoglobulin G - therapeutic use | Immunoglobulin G - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Immunosuppressive Agents - adverse effects | Aged | Adalimumab | Azathioprine - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 08/2013, Volume 62, Issue Suppl 2, pp. A26 - A26
Introduction Azathioprine, an important immunomodulator in the management of Inflammatory Bowel Disease (IBD), has potential serious side-effects about which... 
GASTROENTEROLOGY & HEPATOLOGY | Inflammatory bowel diseases | Pancreatitis | Crohn's disease | Lymphoma | Patients | Blood | Inflammatory bowel disease | Side effects | Intestine | Lymphomas | Skin | Colon | Azathioprine | Neutropenia | Ulcerative colitis
Journal Article
08/2007
A 60 year-old male was initiated on azathioprine 50 mg/day for airborne contact dermatitis. As the patient showed a satisfactory response to this initial... 
airborne contact dermatitis | shock | Azathioprine
Web Resource
Journal of Crohn's & colitis, ISSN 1873-9946, 06/2017, Volume 11, Issue 6, pp. 680 - 689
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198184 - e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Medical services | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2011, Volume 365, Issue 20, pp. 1886 - 1895
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article